Sickle cell transcriptome was analyzed using whole blood clinical specimens on the Affymetrix Human Exon 1.0 ST arrays and Illumina’s deep sequencing technologies. Data analysis indicated a strong con
A comparison of the selected high-throughput technologies for miRNA profiling in cerebrospinal fluid and the number and quantity of miRNAs detected in the study.
Note: Selection criteria for differential expression required genes to have fold-change greater than 2.0, FDR-adjusted p less than 0.05, and expression value greater than the median of values in all c
